AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beer, A. J.
Right arrow Articles by Rummeny, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beer, A. J.
Right arrow Articles by Rummeny, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.04.1545
AJR 2006; 186:1639-1650
© American Roentgen Ray Society


Original Research

Comparison of 16-MDCT and MRI for Characterization of Kidney Lesions

Ambros J. Beer, Martin Dobritz, Niko Zantl, Gregor Weirich, Jens Stollfuss and Ernst J. Rummeny

Department of Radiology, Technische Universitaet Munichen, Ismaninger Strasse 21, Munich, Germany, 81675.

Received January 25, 2005; accepted after revision August 9, 2005.

 
Address correspondence to A. J. Beer (beer{at}roe.med.tum.de).


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The objective of our study was to compare the diagnostic performance of 16-MDCT with that of MRI in the characterization of kidney lesions.

SUBJECTS AND METHODS. Twenty-eight patients with kidney lesions detected with sonography and requiring further evaluation were examined. MDCT was performed in the unenhanced, arterial, and portal venous phases. MRI was performed at 1.5 T with T2- and T1-weighted and dynamic gadolinium-enhanced sequences. Consensus reading was done by two radiologists. Image quality was rated on a four-point scale. Classification of lesions as surgical or nonsurgical was done with five levels of confidence, and it was required that a definite diagnosis be assigned to each lesion. The 1997 TNM classification was used for staging. Statistical analysis was done by receiver operating characteristic analysis or paired Student's t test. Histologic or follow-up findings at least 12 months after the primary diagnosis served as the standard of reference.

RESULTS. The image quality of MDCT (mean grade, 2.79 on a 0-3 scale) was superior to that of MRI (1.93; p < 0.01). The area under the curve for differentiating surgical from nonsurgical lesions was 0.979 for MDCT and 0.957 for MRI with resulting sensitivity and specificity values of 92.3% and 96.3% for MDCT and 92.3% and 91.3% for MRI. Sensitivity and specificity for definite classification of the lesions were 93.8% and 68.4% for MDCT and 93.8% and 71.4% for MRI.

CONCLUSION. Both MDCT and MRI are excellent for differentiating surgical from nonsurgical kidney lesions. Both methods have low specificity for the differentiation of benign from malignant lesions.

Keywords: CT technique • genitourinary tract imaging • kidney • MDCT • MRI


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
The widespread use of sonography, CT, and MRI in the field of abdominal imaging has led to an increase in the incidental detection of renal lesions, which require further diagnostic evaluation [1]. This evaluation is most often done with CT or MRI, both of which are well-established techniques in the field of renal imaging [1-5]. Although CT is the preferred technique because of availability, lower cost, and spatial resolution, it is still unclear which method is best suited for renal imaging with state-of-the-art techniques. There have been few comparisons of MRI and CT in the same patient, and only single-detector or four-slice CT was used in those studies [1-4]. Furthermore, most reports of renal imaging with MRI and CT emphasize accuracy in TNM staging of malignant renal lesions [6-9]. An issue of equal importance, however, is the capability of MRI and CT to provide enough information to allow differentiation of surgical from nonsurgical kidney lesions incidentally de tected with another imaging technique, such as sonography or, less often, excretory urography. Surgical lesions in this context are lesions in which malignancy cannot be excluded on the basis of imaging characteristics alone and that necessitate further surgical exploration for final diagnosis. This definition applies to most solid renal masses without fatty content and all cystic Bosniak type 3 and type 4 lesions [1, 2].

The primary goal of this study was to evaluate the diagnostic performance of state-of-the-art MDCT and MRI for differentiation of surgical from nonsurgical kidney lesions. The techniques were compared with regard to image quality and definite classification of the lesions.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Patients
Between July 2002 and April 2003, 75 patients arrived in the department of urology at our institution with kidney lesions that had been detected with sonography and required further evaluation by imaging, operation, or both. Twenty-eight of the patients (eight women, 20 men; age range, 27-84 years; mean age, 64.8 ± 13.9 years [SD]) fulfilled the inclusion criteria and were examined in this prospective study. The inclusion criteria were presence of a kidney lesion that could not be classified with sonography alone and that required further diagnostic evaluation, a minimum age of 18 years, and the ability to give written informed consent. Exclusion criteria were pregnancy, previous CT examination of sufficient quality (helical CT, slice thickness less than 8 mm, unenhanced and delayed scans [60-120 sec postinjection] covering the entire kidneys), and contraindications to iodinated contrast agents or to MRI examination. Patients were also excluded from the study when kidney lesions were present that could be confidently classified on the basis of sonographic findings alone or when follow-up by sonography was considered sufficient (simple cyst, homogeneous hyperechoic lesion). The interval between MRI and MDCT examinations was less than 3 weeks. All patients gave written informed consent for the study protocol, which had been approved by the institutional ethics committee.


Figure 1
View larger version (6K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 —Graph shows comparison of mean image quality of MRI and MDCT on scale of 0-3. Difference is statistically significant (p <0.001).

 


Figure 2
View larger version (8K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 —Graph shows results of receiver operating characteristic analysis of MDCT (solid line; Az = 0.979) and MRI (dotted line; Az = 0.957).

 
A total of 44 lesions had been detected sonographically. Nineteen (43.2%) of the lesions were predominantly solid lesions, 12 (27.3%) were simple cystic lesions larger than 15 mm, 11 (25.0%) were complex cystic lesions, and two (4.5%) were inhomogeneous hyperechoic solid lesions. A total of 56 kidney lesions were detected with MDCT and MRI. The final diagnoses were 16 renal cell carcinomas, 15 Bosniak type 1 cysts larger than 15 mm, nine Bosniak type 2 cysts, nine oncocytomas, three angiomyolipomas, three inflammatory lesions, and one adenoma. Simple Bosniak type 1 cysts smaller than 15 mm were not included in the evaluation.

Eighteen patients underwent surgery on the basis of reported imaging findings. Histologic examination revealed 13 renal cell carcinomas (nine clear cell, three papillary, one chromophobe) and one angiomyolipoma in 13 patients; nine oncocytomas in two patients (one patient with four oncocytomas in one kidney and one patient with three oncocytomas in the left and two oncocytomas in the right kidney); inflammatory lesions in two patients; and an adenoma in one patient. Six Bosniak type 1 cysts larger than 15 mm were also found in the resection specimen.

In three patients with very large inoperable renal cell carcinoma, the final diagnosis was established at autopsy. Therefore 35 lesions were confirmed at histologic examination. Confirmation of the remaining 21 lesions was based on clinical follow-up evaluation (all cases) and imaging follow-up examinations 6 and 12 months after the primary sonographic diagnosis (two angiomyolipomas, six Bosniak type 1 cysts, and one case of inflammation) or helical CT (nine Bosniak type 2 cysts and three type 1 cysts).

Imaging Technique: MDCT
All studies were performed with a 16-MDCT scanner (Somatom Sensation 16, Siemens Medical Solutions). A triphasic imaging protocol consisting of an unenhanced phase, an arterial phase, and a portal venous phase was used. All scans were obtained with 16 x 0.75 mm collimation at 120 kV and 200 mAs with the CareDose mode (Siemens Medical Solutions). The unenhanced and arterial phases included the kidneys only, and the portal venous phase included the entire abdomen. For better delineation of intestinal structures, oral contrast medium was used in cases in which malignancy was strongly suspected (n = 20; 30 mL of meglumine ioxithalamate [Telebrix, Guerbet] in 1,000 mL of water 60 min before scanning). After the unenhanced scan was obtained, 20 mL of contrast medium was administered IV to enhance the renal pelvis and ureters, which were imaged with low-dose control scans at the level of the ureteropelvic junction after 3-5 min. After opacification of the collection system, 120 mL of iomeprol contrast medium (Imeron 300, Altana) was administered at a flow rate of 4-5 mL/sec followed by a saline flush of 30 mL at the same flow rate as the contrast medium (split-bolus technique). For the arterial phase, the CareBolus technique was used. This technique allows automatic start of the scan after a certain level of opacification (>120 H) is reached in a region of interest placed by the user in the aorta at the level of the renal arteries. After 80 sec, the portal venous scan of the abdomen was started. All scans were obtained in deep inspiration. Each phase was reconstructed with a slice thickness of 4 mm and a reconstruction increment of 4 mm with a B30 kernel for filming on hard copies. In addition, each phase was reconstructed with a 0.75-mm slice thickness and 0.7-mm reconstruction increment (B30 kernel) for 3D applications. Semicoronal re-constructions parallel to the kidneys in the portal venous phase with a slice thickness of 4 mm were routinely obtained. All data were stored on optical disks and transferred to a Leonardo workstation (Siemens Medical Solutions) for further 3D reconstruction and image analysis.


Figure 3
View larger version (123K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A —54-year-old man with complicated cystic lesion on right side not correctly classified with MRI or CT in receiver operating characteristic (ROC) analysis. MR images show small hyperintense cortical lesion (arrows) not as intense as fluid compared with renal collecting system. No substantial contrast enhancement is present in T1-weighted contrast-enhanced images with fat suppression. T2-weighted sequence with fat saturation

 


Figure 4
View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B —54-year-old man with complicated cystic lesion on right side not correctly classified with MRI or CT in receiver operating characteristic (ROC) analysis. MR images show small hyperintense cortical lesion (arrows) not as intense as fluid compared with renal collecting system. No substantial contrast enhancement is present in T1-weighted contrast-enhanced images with fat suppression. T1-weighted axial image, late venous phase.

 


Figure 5
View larger version (162K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C —54-year-old man with complicated cystic lesion on right side not correctly classified with MRI or CT in receiver operating characteristic (ROC) analysis. MR images show small hyperintense cortical lesion (arrows) not as intense as fluid compared with renal collecting system. No substantial contrast enhancement is present in T1-weighted contrast-enhanced images with fat suppression. T1-weighted dynamic coronal image, venous phase.

 


Figure 6
View larger version (175K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3D —54-year-old man with complicated cystic lesion on right side not correctly classified with MRI or CT in receiver operating characteristic (ROC) analysis. CT scans corresponding to A-C show lesion (arrows) is mean 20 H in unenhanced scan (D) but no measurable enhancement in axial (E) or coronal (F) view of venous scan. Peripheral enhancement could not be excluded, which led to classification of level 3 (not sure) in ROC analysis and Bosniak classification of 2f. Histologic examination of surgical specimen revealed small clear cell carcinoma.

 


Figure 7
View larger version (169K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3E —54-year-old man with complicated cystic lesion on right side not correctly classified with MRI or CT in receiver operating characteristic (ROC) analysis. CT scans corresponding to A-C show lesion (arrows) is mean 20 H in unenhanced scan (D) but no measurable enhancement in axial (E) or coronal (F) view of venous scan. Peripheral enhancement could not be excluded, which led to classification of level 3 (not sure) in ROC analysis and Bosniak classification of 2f. Histologic examination of surgical specimen revealed small clear cell carcinoma.

 


Figure 8
View larger version (175K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3F —54-year-old man with complicated cystic lesion on right side not correctly classified with MRI or CT in receiver operating characteristic (ROC) analysis. CT scans corresponding to A-C show lesion (arrows) is mean 20 H in unenhanced scan (D) but no measurable enhancement in axial (E) or coronal (F) view of venous scan. Peripheral enhancement could not be excluded, which led to classification of level 3 (not sure) in ROC analysis and Bosniak classification of 2f. Histologic examination of surgical specimen revealed small clear cell carcinoma.

 
Imaging Technique: MRI
MRI was performed with a 1.5-T superconducting imaging system (Gyroscan Intera, Philips Medical Systems) equipped with a gradient system with an amplitude of 23 mT/m in 200 µsec. A phased-array surface coil was centered over the patient's abdomen at the level of the kidneys. The following sequences were used: T2-weighted fast spin-echo sequence (TR/TE, 2,200/120; echo-train length, 23; number of signals averaged, 4) in the axial plane with spectral presaturation by inversion recovery and a slice thickness of 6 mm (no spacing; respiratory triggering); T1-weighted unenhanced fast spin-echo sequences (500/15; echo-train length, 3; number of signals averaged, 4) with and without spectral presaturation by inversion recovery, slice thickness of 6 mm (no spacing; phase-encoding artifact reduction); dynamic gadolinium-enhanced T1-weighted 2D gradient echo sequence (233/5.6; flip angle, 80°, imaging time, 20 sec; breath-hold in expiration) in the coronal plane, slice thickness of 5 mm at 0, 20, 50, and 160 sec after administration of gadopentetate dimeglumine (Magnevist, Schering) 0.1 mmol/kg body weight IV at a flow rate of 2 mL/sec. The T1-weighted fast spin-echo sequences were repeated after injection of gadolinium.

For all images, parallel imaging was applied with sensitivity encoding at a factor of 2. Sequences were repeated by the technical assistants if there were motion artifacts. A radiologist on site checked the images for quality before the patient left the imager. Image data were saved on optical disks and transferred to a Leonardo workstation for further analysis.


Figure 9
View larger version (119K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A —55-year-old man with histologically confirmed multiple oncocytomas in both kidneys. All were considered surgical lesions. Sonogram shows one solid slightly hyperechoic mass (arrows) in left kidney.

 


Figure 10
View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B —55-year-old man with histologically confirmed multiple oncocytomas in both kidneys. All were considered surgical lesions. MDCT scan shows solid mass (arrow) on left side and two small cortical solid enhancing lesions (arrows) on right side.

 


Figure 11
View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C —55-year-old man with histologically confirmed multiple oncocytomas in both kidneys. All were considered surgical lesions. MR image of right kidney shows small cortical solid enhancing lesion (arrow).

 


Figure 12
View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4D —55-year-old man with histologically confirmed multiple oncocytomas in both kidneys. All were considered surgical lesions. MR image of left kidney shows solid mass (arrow).

 
Image Analysis
All images were interpreted retrospectively by two experienced radiologists in consensus without knowledge of clinical or histologic data. Both reviewers had more than 3 years of experience in genitourinary imaging and were equally trained in reading CT and MR images. CT and MR images were analyzed with a Leonardo workstation in different sessions with at least 8 weeks between sessions. If the two reviewers disagreed, a third fully trained faculty radiologist with more than 3 years of experience in genitourinary imaging was consulted, and the final decision was based on his vote.


Figure 13
View larger version (145K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5A —66-year-old man with angiomyolipoma in left kidney. T1-weighted MR image without fat saturation shows well-delineated lesion (arrow).

 


Figure 14
View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5B —66-year-old man with angiomyolipoma in left kidney. Fat-saturated T1-weighted sequence shows decrease in signal intensity (arrow) compared with A.

 


Figure 15
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5C —66-year-old man with angiomyolipoma in left kidney. Unenhanced MDCT scan shows low fatlike attenuation (mean, -78 H; SD, 12 H) of lesion (arrow).

 


Figure 16
View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5D —66-year-old man with angiomyolipoma in left kidney. Contrast-enhanced MDCT scan shows slight contrast enhancement (arrow). Follow-up after 12 months showed no change.

 
The reviewers assessed overall image quality on a four-point scale from 0 to 3. Grade 0 indicated a diagnosis could not be made. Grade 1 indicated poor image quality; a diagnosis could be made, but severe image artifacts were present (the suspected lesion was seen and a differential diagnosis was established, but some aspects, such as lymph nodes and renal vein thrombosis, could not be properly analyzed). Grade 2 indicated good image quality with only minor image artifacts (e .g., breathing artifacts); all important aspects could be analyzed. Grade 3 indicated excellent image quality; no artifacts.

For differentiation of surgical from nonsurgical lesions, receiver operating characteristic (ROC) analysis was performed with five levels of confidence. Level 1 indicated definitely nonsurgical lesion; level 2, probably nonsurgical lesion; level 3, not sure; level 4, probably surgical lesion; level 5, definitely surgical lesion. All Bosniak types 1 and 2 benign cysts, angiomyolipomas, and areas of inflammation were considered nonsurgical lesions because they can be considered benign solely because of their imaging characteristics. All Bosniak types 3 and 4 cysts and all solid, enhancing lesions (except angiomyolipoma) were considered surgical lesions (including oncocytomas), because malignancy cannot be excluded on the basis of imaging characteristics alone. The threshold for pathologic enhancement was set at a 10-H difference between unenhanced and venous scans.

Reviewers were required to assign a definite diagnosis to each lesion. If histopathologic or follow-up examination confirmed the diagnosis in cases of malignant lesions, the finding was rated true-positive. If histopathologic or follow-up examination confirmed the diagnosis in cases of benign lesions, the finding was rated true-negative. If histopathologic or follow-up examination revealed a malignant instead of a suspected benign lesion, the finding was rated false-negative. If histopathologic or follow-up examination revealed a benign instead of a suspected malignant lesion, the finding was rated false-positive. The 1997 International Union Against Cancer classification was used for staging.

Statistical Analysis
ROC analysis was performed for MDCT and MRI separately to determine the diagnostic performance of both techniques in differentiation of surgical from nonsurgical lesions. Area under the curve (Az) was calculated by logistic regression analysis. The optimal cutoff value was defined as the cutoff value that maximized sensitivity and specificity and was determined for each ROC curve separately. The corresponding 95% confidence interval (CI) was obtained for each sensitivity and specificity value at each level of confidence. Differences between ROC curves were tested on the basis of 95% CI of the difference of the Az values. For comparison of image quality, a paired Student's t test was used. All statistical tests were performed at the 5% level of statistical significance with the Stat-View program version 5.0 (SAS Institute, 1992-1998) or MedCalc version 6.15.000 (Med-Calc, 1993-2002).


Figure 17
View larger version (154K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6A —68-year-old woman with clear cell carcinoma of right kidney. MDCT scans (A-D) have excellent image quality (grade 3) with clear depiction of borders of tumor (arrow), especially in arterial phase (A, C). MR images (E, F) have good image quality (grade 2), showing tumor (arrow) with few motion artifacts. Axial arterial phase MDCT scan.

 


Figure 18
View larger version (154K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6B —68-year-old woman with clear cell carcinoma of right kidney. MDCT scans (A-D) have excellent image quality (grade 3) with clear depiction of borders of tumor (arrow), especially in arterial phase (A, C). MR images (E, F) have good image quality (grade 2), showing tumor (arrow) with few motion artifacts. Axial portal venous phase MDCT scan.

 


Figure 19
View larger version (162K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6C —68-year-old woman with clear cell carcinoma of right kidney. MDCT scans (A-D) have excellent image quality (grade 3) with clear depiction of borders of tumor (arrow), especially in arterial phase (A, C). MR images (E, F) have good image quality (grade 2), showing tumor (arrow) with few motion artifacts. Coronal arterial phase MDCT scan.

 


Figure 20
View larger version (161K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6D —68-year-old woman with clear cell carcinoma of right kidney. MDCT scans (A-D) have excellent image quality (grade 3) with clear depiction of borders of tumor (arrow), especially in arterial phase (A, C). MR images (E, F) have good image quality (grade 2), showing tumor (arrow) with few motion artifacts. Coronal portal venous phase MDCT scan.

 


Figure 21
View larger version (130K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6E —68-year-old woman with clear cell carcinoma of right kidney. MDCT scans (A-D) have excellent image quality (grade 3) with clear depiction of borders of tumor (arrow), especially in arterial phase (A, C). MR images (E, F) have good image quality (grade 2), showing tumor (arrow) with few motion artifacts. T2-weighted spectral presaturation by inversion recovery axial MR image.

 


Figure 22
View larger version (166K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6F —68-year-old woman with clear cell carcinoma of right kidney. MDCT scans (A-D) have excellent image quality (grade 3) with clear depiction of borders of tumor (arrow), especially in arterial phase (A, C). MR images (E, F) have good image quality (grade 2), showing tumor (arrow) with few motion artifacts. T1-weighted gradient-refocused echo coronal MR image.

 


Figure 23
View larger version (117K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7A —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. Sonogram shows tumor (arrows) at upper pole.

 


Figure 24
View larger version (96K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7B —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. Sonogram shows cystic lesion (arrow) at lower pole.

 


Figure 25
View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7C —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. MR images show solid T2-weighted hyperintense (C) and contrast-enhancing lesion (D, unenhanced T1-weighted MRI; E, contrast-enhanced T1-weighted MRI) at upper pole and two cystic lesions without contrast enhancement at lower pole of kidney.

 


Figure 26
View larger version (97K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7D —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. MR images show solid T2-weighted hyperintense (C) and contrast-enhancing lesion (D, unenhanced T1-weighted MRI; E, contrast-enhanced T1-weighted MRI) at upper pole and two cystic lesions without contrast enhancement at lower pole of kidney.

 


Figure 27
View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7E —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. MR images show solid T2-weighted hyperintense (C) and contrast-enhancing lesion (D, unenhanced T1-weighted MRI; E, contrast-enhanced T1-weighted MRI) at upper pole and two cystic lesions without contrast enhancement at lower pole of kidney.

 


Figure 28
View larger version (60K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7F —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. MDCT scans show solid lesion at upper pole and two cystic lesions at lower pole with equal image quality compared to MRI (F, contrast-enhanced axial plane; G, unenhanced and H, enhanced coronal reformations).

 


Figure 29
View larger version (116K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7G —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. MDCT scans show solid lesion at upper pole and two cystic lesions at lower pole with equal image quality compared to MRI (F, contrast-enhanced axial plane; G, unenhanced and H, enhanced coronal reformations).

 


Figure 30
View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7H —74-year-old woman with clear cell carcinoma of right kidney. Excellent image quality (grade 3) in both MR images and MDCT scans. Large hypervascular tumor and Bosniak type 1 cysts were correctly evaluated with both techniques, and results were histologically confirmed. MDCT scans show solid lesion at upper pole and two cystic lesions at lower pole with equal image quality compared to MRI (F, contrast-enhanced axial plane; G, unenhanced and H, enhanced coronal reformations).

 

Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Assessment of image quality showed that all images were of diagnostic quality. Six MR images were considered of poor quality with many artifacts (grade 1), whereas none of the MDCT scans was of poor quality. Eighteen MR images were of good quality (grade 2), and four images were of excellent quality (grade 3). Six MDCT scans were of good image quality and 22 scans of excellent image quality. The mean image quality grade for all MDCT scans was 2.79 ± 0.42. For the MR images, the mean image quality grade was 1.93 ± 0.60. The difference between the image quality of MDCT and that of MRI was statistically significant (p < 0.001). The results are summarized in Figure 1.

In differentiation of surgical from nonsurgical kidney lesions, both methods performed comparably. The ROC analysis resulted in Az values of 0.979 for MDCT (95% CI, 0.948-1.009) and 0.957 for MRI (95% CI, 0.895-1.018) (Fig. 2). Both results were within the corresponding 95% CI, and the differences between the ROC curves were not statistically significant (p = 0.739). The cut-off value that optimized sensitivity and specificity for MDCT was level 4, meaning that all lesions characterized as level 4 (probably surgical lesions) and level 5 (definitely surgical lesion) were considered surgical lesions. At this level, sensitivity was 92.3% and specificity was 96.3%. For MRI, the optimal cutoff value was the same confidence level as for MDCT, resulting in a sensitivity of 92.3% and a specificity of 91.3%.


Figure 31
View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8A —78-year-old man with clear cell carcinoma of right kidney and invasion of renal vein and inferior vena cava. Sonogram shows large mass in right kidney (arrow).

 


Figure 32
View larger version (154K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8B —78-year-old man with clear cell carcinoma of right kidney and invasion of renal vein and inferior vena cava. Axial portal venous phase MDCT scan of excellent image quality (grade 3) clearly shows tumor (arrow).

 


Figure 33
View larger version (141K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8C —78-year-old man with clear cell carcinoma of right kidney and invasion of renal vein and inferior vena cava. Axial arterial phase MDCT scan in curved planar reformation shows tumor thrombus (arrow). Tumor thrombus was missed on MR images because of severe motion artifacts. MDCT scan has excellent image quality (grade 3).

 
In exact diagnosis of the lesions, MDCT correctly depicted 15 of 16 renal cell carcinomas (sensitivity, 93.3%; Fig. 3A, 3B, 3C, 3D, 3E and 3F) and correctly depicted 26 of 38 benign lesions (specificity, 68.4%). The positive predictive value (PPV) was 55.6% (15/27), and the negative predictive value (NPV) was 96.3% (26/27). All oncocytomas were falsely classified as renal cell carcinomas (Fig. 4A, 4B, 4C and 4D). One inflammatory lesion was falsely classified as carcinoma. All angiomyolipomas, two inflammatory lesions, and one adenoma were correctly recognized as benign lesions (Fig. 5A, 5B, 5C and 5D). Two Bosniak type 2 cysts smaller than 15 mm were falsely classified as Bosniak type 1 cysts on MDCT.

MRI also correctly depicted 15 of 16 renal cell carcinomas (sensitivity, 93.3%) and correctly depicted 25 of 35 benign lesions (specificity, 71.4%; Figs. 6A, 6B, 6C, 6D, 6E, 6F and 7A, 7B, 7C, 7D, 7E, 7F, 7G and 7H). The PPV was 55.6% (15/27) and the NPV was 96.3% (26/27). Again, all oncocytomas were falsely classified as carcinomas. One adenoma was misclassified as a malignant lesion. All angiomyolipomas and inflammatory lesions were correctly classified. Three benign lesions smaller than 10 mm (one 6-mm angiomyolipoma and oncocytomas measuring 6 mm and 7 mm) were detected with MDCT but not with MRI. Two Bosniak type 2 cysts smaller than 15 mm with small calcifications were falsely classified as Bosniak type 1 cysts, because the calcifications were not detected with MRI performed with our MRI protocol.

On a per-patient basis, the malignant lesions of 15 of 16 patients were correctly classified with both MDCT and MRI, resulting in a sensitivity of 93.8% for both techniques. The benign lesions of eight of 12 patients were correctly classified with both MDCT and MRI, resulting in a specificity of 66.7% for both techniques. The PPV and NPV for both MDCT and MRI on a per-patient basis were 78.9% (15/19) and 88.9% (8/9).

TNM staging of surgically removed malignant lesions (n = 13) was correct for both MDCT and MRI in eight of 13 lesions. MRI interpretation led to overstaging of three lesions and understaging of two lesions. MDCT interpretation led to overstaging of four lesions and understaging of one lesion. Minimal invasion of renal veins in the hilus (stage T3a) was missed with both techniques, and one of three surgically proven tumor thrombi in the renal veins (stage T3b) was missed with MRI (Figs. 8A, 8B and 8C). Overstaging with both techniques was always caused by false classification of enlarged lymph nodes (> 15 mm) as malignant lymph nodes (N1). These nodes proved to be reactive lymph nodes at histologic examination.


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
In this study we compared the performance of 16-MDCT and MRI in the characterization of kidney lesions. MDCT proved superior to MRI with regard to image quality. Both MDCT and MRI proved excellent for differentiating surgical from nonsurgical kidney lesions. However, in definite classification of lesions, both MDCT and MRI had good sensitivity and NPV but limited specificity and low PPV.

We focused on differentiation of surgical from nonsurgical renal lesions because surgeons determining whether a patient needs an operation or conservative care base the decision mainly on imaging findings. ROC analysis showed no statistical difference in the performance of MDCT and MRI in differentiation of surgical from nonsurgical renal lesions and revealed sensitivity and specificity of 92.3% and 96.3% for MDCT and 92.3% and 91.3% for MRI. Concerning reviewer confidence, both methods performed equally and had an optimal cutoff at a confidence level of 4. CT has been a commonly used tool in the evaluation of kidney lesions for many years, reflected, for example, in the Bosniak classification of cystic kidney lesions introduced in 1986 [1, 10]. This classification is based on CT criteria [1, 2] but can also be applied to MR images. In our study, this classification was used for evaluation of cystic renal masses, which are in many cases the most difficult lesions to evaluate.

Similar to the approach in our study, that used by Israel et al. [11] was a comparison of CT (helical CT with single-detector to four-slice scanners) and MRI in a study involving 59 patients with cystic renal masses classified by the Bosniak system. CT and MRI findings were similar in most of the cystic masses, but in 10% of cases, the MRI findings led to upgrading of Bosniak type. Our study corroborated this finding in that we found both MDCT and MRI had excellent sensitivity and specificity in differentiation of surgical from nonsurgical kidney lesions. However, we had no cases in which the MRI findings led to upgrading of lesions. This finding may be due to differences in the patient populations, because we evaluated not only cystic but also solid renal lesions. We consequently had fewer complicated cystic lesions in our evaluation, which may explain in part the differences in study outcome. In our study, two large (> 3 cm) cystic carcinomas without contrast enhancement exhibited heterogeneity of cyst contents on MDCT and on MRI, so both techniques provided the same information. Another factor may be that all patients in our study underwent 16-MDCT, which had excellent image quality with high resolution in all image planes. Although there is no direct proof of this hypothesis, Israel et al. also mention as a limitation to their study that only axial CT scans were analyzed and that the multiplanar MR images might have been responsible for the better performance of MRI. A study by Tello et al. [12] emphasized the importance of heterogeneous signal intensity in malignant renal lesions without contrast enhancement on MRI compared with CT. Therefore it cannot be excluded that in some cases of cystic lesions without contrast enhancement, inhomogeneity of the lesion on MRI may lead to an upgrade from nonsurgical (Bosniak 2) to surgical lesion (Bosniak 3).

To the best of our knowledge only two studies have compared state-of-the-art helical CT and MRI in evaluation of renal lesions [6, 8]. In the study by Walter et al. [6], all histologically proven masses were successfully detected with both MRI and CT. The two techniques also had equal performance in the characterization and staging of renal lesions. These results corresponded to our findings. However, the study by Walter et al. focused mainly on solid renal lesions, and the authors noted that there were no complicated renal cysts in the patient sample. Complicated renal cysts are the most interesting lesions for radiologists, because in many cases the imaging findings have a direct influence on patient management. In their study, Hallscheidt et al. [8] also compared MDCT and MRI but only for staging of renal cell carcinoma and not for characterization of kidney lesions.

Our examinations not only corroborated the findings of the other studies but also contribute to the growing literature on evaluation of various renal lesions, that is, solid and cystic lesions, including complicated cysts. Moreover, to our knowledge, this study is the first comparison of 16-MDCT and 1.5-T MRI in the evaluation of renal masses in the same patient group. This factor is important because dramatic improvement in the quality of CT since the introduction of MDCT has led to high accuracy in the preoperative evaluation of renal cell carcinoma [13]. The image quality of MDCT in our study was significantly better than that of MRI. Classification and delineation of small cortical tumors and large tumors were equally good or better with MDCT compared with MRI. MDCT also delineated all tumor thrombi in the renal veins and vena cava, whereas one thrombus was missed on MRI because of the presence of motion artifacts. In addition to the high spatial resolution of MDCT and the capability for high-quality reconstructions, an explanation for this result may be the shorter examination time of MDCT compared with MRI. This explanation remains speculative because we did not perform a systematic analysis of the influence of acquisition time on image quality. The anatomic detail achieved with MDCT is, for example, of paramount importance for planning nephron-sparing renal surgery [14, 15], although this feature applies not only to 16-MDCT but also to 4-MDCT. The relation of the tumor to adjacent vessels and to the renal collecting system was well visualized with MDCT because of the split-bolus technique we used for opacification of the renal collecting system and because of the use of multiplanar reformations. The split-bolus technique also obviates a separate urographic scan. Consequently, some advantages of MRI over incremental or single-detector CT, such as high-quality multiplanar imaging and better delineation of tumor thrombus [16], may no longer apply with the use of MDCT.

We evaluated the performance of MDCT and MRI in differentiation of benign from malignant lesions. Although the sensitivity was high at 93.8% for both MDCT and MRI, specificity was quite low at 68.4% and 71.4%, respectively, values reflected in low PPVs. Both techniques were very good in detection of malignant renal lesions, and the probability of misclassifying a malignant lesion as benign is low. Many lesions managed surgically, however, turned out to be benign after the operation. Although this result may have been due in part to the large number of oncocytomas in our study (two patients with nine oncocytomas), it reflects a common problem in renal imaging: Solid enhancing lesions (without fat) must be considered surgical lesions, because no definite imaging criteria exist for differentiating carcinomas from adenomas and oncocytomas [17-19].

There were limitations to our study. The image analysis was done in consensus, and therefore interobserver variability was not evaluated. In addition, the sample size was relatively small, and pathologic correlation was not available in all cases. Although follow-up findings were analyzed for the lesions for which there was no pathologic correlation, the follow-up time was not longer than 12 months, because 16-MDCT had been only recently introduced in our department. Therefore some Bosniak type 2 cysts may turn out to be malignant, although this outcome is not likely, according to the literature [20-22]. We also did not include renal masses seen incidentally at CT or MRI examinations. Exclusion of these lesions may have affected our specificity, because more small and fewer clearly solid cancers probably would have been included. Moreover, we included both sonographically solid and sonographically cystic renal lesions in our study. Therefore it cannot be excluded that the results may be different in a population with predominantly cystic lesions, because MRI may be superior to CT in the detection of inhomogeneities in cystic lesions [11].

In conclusion, both 16-MDCT and MRI perform excellently in differentiation of surgical from nonsurgical renal lesions that have been detected with sonography. However, neither technique can be used to further differentiate benign from malignant tumors in cases of solid enhancing lesions without fat. Because it has a shorter acquisition time, wider availability, and is less expensive than MRI, MDCT continues to be the preferred technique for further evaluation of sonographically detected renal masses, especially when malignancy is already strongly suspected, as in solid heterogeneous masses. However, MRI is a useful alternative in cases of contraindications to use of iodinated contrast agents or when radiation dose is an issue, as in imaging of young patients, repeated follow-up examinations, and imaging during pregnancy.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Masood J, Lane T, Koye B, Vandal MT, Barua JM, Hill JT. Renal cell carcinoma: incidental detection during routine ultrasonography in men presenting with lower urinary tract symptoms. BJU Int2001; 88:671 -674[Medline]
  2. Silverman SG, Lee BY, Seltzer SE, et al. Small (< 3 cm) renal masses: correlation of spiral CT features and pathologic findings. AJR 1994; 163:597 -605[Abstract/Free Full Text]
  3. Zagoria RJ, Bechtold RE, Dyer RB. Staging of renal adenocarcinoma: role of various imaging procedures. AJR1995; 164:363 -370[Abstract/Free Full Text]
  4. Semelka RC, Hricak HH, Stevens S, Finegold R, Tomei E, Carrol PR. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 1991;178 : 803-809[Abstract/Free Full Text]
  5. Kopka L, Fischer U, Zoeller G, et al. Dual phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. AJR 1997; 169:1573 -1578[Abstract/Free Full Text]
  6. Walter C, Kruessell M, Gindele A, Brochhagen HG, Gossmann A, Landwehr P. Imaging of renal lesions: evaluation of fast MRI and helical CT. Br J Radiol 2003;76 : 696-703[Abstract/Free Full Text]
  7. Hallscheidt P, Stolte E, Roeren T, Pomer S, Drehmer I, Kauffmann GW. The staging of renal-cell carcinomas in MRT and CT: a prospective histologically controlled study. Rofo1998; 168:165 -170[Medline]
  8. Hallscheidt PJ, Bock M, Riedasch G, et al. Diagnostic accuracy of staging renal cell carcinomas using multidetector-row computed tomography and magnetic resonance imaging: a prospective study with histopathologic correlation. J Comput Assist Tomogr 2004;28 : 333-339[CrossRef][Medline]
  9. Bosniak MA. The current radiological approach to renal cysts. Radiology 1986;158 : 1-10[Abstract/Free Full Text]
  10. Dunnick NR, Sandler CM, Newhouse JH, Amis ES Jr. Textbook of uroradiology, 3rd ed. Philadelphia, PA: Lippincott 2001: 123-149
  11. Israel GM, Hindman N, Bosniak MA. Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 2004;231 : 365-371[Abstract/Free Full Text]
  12. Tello R, Davison BD, ÓMalley M, et al. MR imaging of renal masses interpreted on CT to be suspicious. AJR2000; 174:1017 -1022[Abstract/Free Full Text]
  13. Catalano C, Frailoi F, Laghi A, et al. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR 2003;180 : 1271-1277[Abstract/Free Full Text]
  14. Smith PA, Marshall FF, Corl FM, Fishman EK. Planning nephron-sparing renal surgery using 3 D helical CT angiography. J Comput Assist Tomogr 1999;23 : 649-654[CrossRef][Medline]
  15. Hallscheidt P, Schoenberg S, Schenk JP, Zuna I, Petirsch O, Riedasch G. Multi-slice CT in the planning of nephron-sparing interventions for renal cell carcinoma: prospective study correlated with histopathology. Rofo 2002; 174:898 -903[Medline]
  16. Pretorius ES, Wickstrom ML, Siegelman ES. MR imaging of renal neoplasms. Magn Reson Imaging Clin N Am2000; 8:813 -836[Medline]
  17. Kodama K, Nagano K, Akimoto M, Suzuki S. Small renal oncocytoma with central cystic degeneration. Int J Urol2004; 11:110 -113[Medline]
  18. Li G, Guilleron M, Gentil-Perret A, Tostain J. Characteristics of image-detected solid renal masses: implication for optimal treatment. Int J Urol 2004;11 : 63-67[CrossRef][Medline]
  19. Schatz SM, Lieber MM. Update on oncocytoma. Curr Urol Rep 2003; 4:30 -35[Medline]
  20. Bosniak MA. Diagnosis and management of patients with complicated cystic lesions of the kidney. AJR 1997;169 : 819-821[Free Full Text]
  21. Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol 1997;157 : 1852-1853[CrossRef][Medline]
  22. Kreft B, Schild HH. Cystic renal lesions. Rofo 2003; 175:892 -903[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
C. S. Ng, C. G. Wood, P. M. Silverman, N. M. Tannir, P. Tamboli, and C. M. Sandler
Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance
Am. J. Roentgenol., October 1, 2008; 191(4): 1220 - 1232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. F. Meloni, M. Bertolotto, C. Alberzoni, S. Lazzaroni, C. Filice, T. Livraghi, and G. Ferraioli
Follow-Up After Percutaneous Radiofrequency Ablation of Renal Cell Carcinoma: Contrast-Enhanced Sonography Versus Contrast-Enhanced CT or MRI
Am. J. Roentgenol., October 1, 2008; 191(4): 1233 - 1238.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map